Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...Basic processes such as signing off of music used for adverts or addressing technical glitches have required co-ordination with counterparts in China, several people said....
...BioNTech and Pfizer have said the patents are invalid....
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...After raking in billions of dollars through sales of the Covid vaccine it co-developed with Germany’s BioNTech during the pandemic and seeing share prices surge, Pfizer has struggled to reorientate its pipeline...
...Pfizer needs to convince investors that Covid-19 treatments are not its only source of success. So far, it has failed....
Case studies in best practice among general counsel and company legal teams in North America
...Pfizer will not take the twice-daily formulation into late-stage trials but will focus on developing a pill to be taken once a day....
...wants a pivot in the biotech’s sales strategy for its Covid-19 shot, which is based on traditional vaccine technology, to target older people unnerved by rare side effects associated with mRNA jabs from Pfizer...
...Panuwat’s company, Medivation, was bought in 2016 by Pfizer for $14bn. But the stock he purchased at the time was not that of Medivation....
...Bain & Co’s latest private equity review gives a longer answer. This was expertly covered in MainFT upon release, but we thought we’d take the chart-curious through an extended parsing of the report....
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
...The Tesla co-founder’s frustration with Delaware law has brought unprecedented attention to the state this year....
...Along with striking a co-brand deal with CVS to offer Hyrimoz at a discounted price of $1,315 a month, Sandoz has a higher list price version of the biosimilar, priced similarly to Humira at more than $6,000...
...Yet Pfizer’s $19bn in Paxlovid sales were almost a fifth of its 2022 total....
Energy watchdog’s forecast runs counter to sentiment among many carmakers struggling to sell battery-run vehicles
...overseas co-head is made the scapegoat and fired....
...The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US....
Carriers have come to rely on check-in charges as a source of revenue but face new disclosure rules
ADM, Chemours, Mattel and NYCB are among groups admitting that weaknesses in controls delayed financial reports
...In a statement, Pfizer said the alleged conduct was a “violation of the company’s policies” and that it was “co-operating with the government’s investigation”....
...From 2025, European carmakers must comply with new standards for average fleet CO₂ emissions. Some are offering discounts on BEVs to avoid fines next year....
...Among the notable patent expiries this decade is BMS and Pfizer’s Eliquis blood clot treatment from 2026. BMS will also lose US exclusivity on its lung cancer treatment Opdivo in 2028....
...The numbers, revealed in consultancy firm Bain & Co’s annual private equity report, show how rapidly the industry has grown over the past decade, as well as the challenges it faces from higher interest rates...
International Edition